Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Enhancing Diabetic Foot Education by Viewing Personal Plantar Pressures [NA]
Clinical trial completed evaluating whether enhancing diabetic foot education by viewing personal plantar pressures impacts outcomes in diab…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 [Phase 3]
Phase 3 trial of relamorelin in diabetic gastroparesis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT [Phase 4]
A Phase 4 trial evaluating different initial insulin dose regimens and their effect on time to glycemic target achievement and treatment saf…
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III [NA]
Completed clinical trial evaluating the effect of a NSS to reduce complications in patients with COVID-19 and comorbidities; results posted …
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes [NA]
Clinical trial update on extended wear infusion set (EWIS) in patients with Type 1 diabetes; study completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: A Patient-Centered PaTH to Addressing Diabetes
Completed Milton S. Hershey Medical Center study NCT02788903 assessing a patient-centered PaTH approach to addressing obesity and diabetes, …
-
EMA approval · 2021-09-23EMA Authorised: Fiasp (insulin aspart) — Novo Nordisk A/S
European Medicines Agency information indicates that Fiasp (insulin aspart) by Novo Nordisk A/S has been authorised for Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions [Phase 4]
Phase 4 trial update evaluating safety and efficacy of empagliflozin in patients with diabetes mellitus undergoing planned percutaneous coro…
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes Mellitus [NA]
Completed clinical trial evaluating an implantable continuous glucose monitoring sensor to improve glycemic control in diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique [Phase 2]
Phase 2 clinical trial updating a new scintigraphy-based method for measuring insulin resistance, compared to the reference technique, compl…
-
FDA approval · 2021-08-20FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
FDA approves a supplemental application for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR, a glucagon injection solution, expanding its device format f…
-
CLINICAL_TRIALS research · 2021-08-19Clinical Trial Update: Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
A method development clinical trial evaluating a hyperinsulinemic-hypoglycemic clamp technique to study hypoglycemia in diabetes.
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 [Phase 3]
Phase 3 study evaluating relamorelin in diabetic gastroparesis was terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: TExT-MED + FANS Full Trial [Phase 2]
Phase 2 trial update for TExT-MED + FANS in diabetes has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital [Phase 4]
Phase 4 trial comparing SoloSTAR with syringe-administered glargine insulin in diabetic patients; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Dexcom G6 Observational Study [NA]
Observational study update for Dexcom G6 in diabetes; study completed with results posted in 2021.
-
FDA approval · 2021-07-29FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for the glucagon product from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 [Phase 3]
A Phase 3 study of relamorelin in diabetic gastroparesis was terminated; results are posted.
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Improving Diabetes Care Through Effective Personalized Patient Portal Interactions [NA]
A completed clinical trial assessing personalized patient portal interactions to improve diabetes care.
-
FDA label_change · 2021-07-15FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
FDA approved a supplemental application for GVOKE HYPOPEN 0.5 mg auto-injector (glucagon injection, solution) by Xeris Pharmaceuticals, upda…
-
EMA approval · 2021-07-13EMA Authorised: Levemir (Insulin detemir) — Novo Nordisk A/S
EMA Authorised Levemir (insulin detemir) by Novo Nordisk A/S for diabetes mellitus.
-
CLINICAL_TRIALS research · 2021-06-22Clinical Trial Update: Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study. [NA]
A completed pilot clinical trial evaluating inpatient diabetes management using continuous glucose monitoring devices.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: User Performance Evaluation for DARIO™ BGMS [NA]
Completed clinical trial evaluating user performance with DARIO BGMS for diabetes; results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Treating Diabetic Lipohypertrophy With Intensive Education Versus Standard Care [NA]
Clinical trial comparing intensive education to standard care for treating diabetic lipohypertrophy was terminated; results posted in 2021.
-
CLINICAL_TRIALS research · 2021-06-08Clinical Trial Update: Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome [NA]
Clinical trial update examining the role of cardiac CT in asymptomatic patients with diabetes and metabolic syndrome; study completed with r…